{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T01:25:48Z","timestamp":1790558748750,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1147897"],"award-info":[{"award-number":["1147897"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jdiacomp.2026.109330","type":"journal-article","created":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T05:13:09Z","timestamp":1776575589000},"page":"109330","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Unveiling novel biomarkers for diabetes-related complications through large-scale proteomics analysis: A FIELD sub-study"],"prefix":"10.1016","volume":"40","author":[{"given":"Habib","family":"Francis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej S.","family":"Januszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew B.","family":"O'Rourke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael L.H.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahmida K.","family":"Ema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anandwardhan A.","family":"Hardikar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mugdha V.","family":"Joglekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald C.W.","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeev","family":"Galande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val","family":"Gebski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. John","family":"Simes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia J.","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark P.","family":"Molloy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony C.","family":"Keech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2026.109330_bb0005","series-title":"IDF Diabetes Atlas","author":"International Diabetes Federation","year":"2021"},{"key":"10.1016\/j.jdiacomp.2026.109330_bb0010","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1093\/ndt\/9.7.824","article-title":"Reiter\u2019s disease, keratoderma blennorrhagica and rapidly progressive (crescentic) IgA glomerulonephritis","volume":"9","author":"Inglis","year":"1994","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jdiacomp.2026.109330_bb0015","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1093\/ije\/dyr029","article-title":"Type 2 diabetes incidence and socio-economic position: a systematic review and meta-analysis","volume":"40","author":"Agardh","year":"2011","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jdiacomp.2026.109330_bb0020","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1136\/jech.54.3.173","article-title":"Diabetes prevalence and socioeconomic status: a population based study showing increased prevalence of type 2 diabetes mellitus in deprived areas","volume":"54","author":"Connolly","year":"2000","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/j.jdiacomp.2026.109330_bb0025","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2337\/dc17-1962","article-title":"Global economic burden of diabetes in adults: projections from 2015 to 2030","volume":"41","author":"Bommer","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2026.109330_bb0030","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12933-017-0574-y","article-title":"Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes","volume":"16","author":"Mohammedi","year":"2017","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jdiacomp.2026.109330_bb0035","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1111\/dom.15260","article-title":"Diabetes foot complications and standardized mortality rate in type 2 diabetes","volume":"25","author":"Stedman","year":"2023","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jdiacomp.2026.109330_bb0040","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11886-019-1107-y","article-title":"Epidemiology of diabetes mellitus and cardiovascular disease","volume":"21","author":"Glovaci","year":"2019","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.jdiacomp.2026.109330_bb0045","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1001\/jama.1979.03290450033020","article-title":"Diabetes and cardiovascular disease. The Framingham study","volume":"241","author":"Kannel","year":"1979","journal-title":"JAMA"},{"key":"10.1016\/j.jdiacomp.2026.109330_bb0050","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.2337\/diacare.21.7.1167","article-title":"Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality. The San Antonio Heart Study","volume":"21","author":"Wei","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2026.109330_bb0055","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1007\/PL00002934","article-title":"Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes","volume":"44","author":"Morrish","year":"2001","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2026.109330_bb0060","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s11892-019-1212-8","article-title":"Epidemiology of peripheral neuropathy and lower extremity disease in diabetes","volume":"19","author":"Hicks","year":"2019","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.jdiacomp.2026.109330_bb0065","first-page":"5","article-title":"Updates in diabetic peripheral neuropathy","author":"Juster-Switlyk","year":"2016","journal-title":"F1000Res"},{"key":"10.1016\/j.jdiacomp.2026.109330_bb0070","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41572-019-0092-1","article-title":"Diabetic neuropathy","volume":"5","author":"Feldman","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jdiacomp.2026.109330_bb0075","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/09286580701396720","article-title":"Overview of epidemiologic studies of diabetic retinopathy","volume":"14","author":"Klein","year":"2007","journal-title":"Ophthalmic Epidemiol"},{"key":"10.1016\/j.jdiacomp.2026.109330_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1098-3597(03)90014-7","article-title":"Diabetic nephropathy","volume":"5","author":"Rabkin","year":"2003","journal-title":"Clin Cornerstone"},{"key":"10.1016\/j.jdiacomp.2026.109330_bb0085","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4137\/BMI.S38440","article-title":"Significance of HbA1c test in diagnosis and prognosis of diabetic patients","volume":"11","author":"Sherwani","year":"2016","journal-title":"Biomark Insights"},{"key":"10.1016\/j.jdiacomp.2026.109330_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2021.e05967","article-title":"Time-in-range as a target in type 2 diabetes: an urgent need","volume":"7","author":"Saboo","year":"2021","journal-title":"Heliyon"},{"key":"10.1016\/j.jdiacomp.2026.109330_bb0095","author":"Royal Australian College of General Practitioners (RACGP)"},{"key":"10.1016\/j.jdiacomp.2026.109330_bb0100","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1152\/physrev.00045.2011","article-title":"Mechanisms of diabetic complications","volume":"93","author":"Forbes","year":"2013","journal-title":"Physiol Rev"},{"key":"10.1016\/j.jdiacomp.2026.109330_bb0105","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(05)67667-2","article-title":"Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial","volume":"366","author":"Keech","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jdiacomp.2026.109330_bb0110","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1475-2840-3-9","article-title":"The need for a large-scale trial of fibrate therapy in diabetes: the rationale and design of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study","volume":"3","author":"Investigators FS","year":"2004","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jdiacomp.2026.109330_bb0115","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1016\/S0140-6736(09)60698-X","article-title":"Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trial","volume":"373","author":"Rajamani","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jdiacomp.2026.109330_bb0120","article-title":"Data independent acquisition of plasma biomarkers of response to neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma","volume":"231","author":"O\u2019Rourke","year":"2021","journal-title":"J Proteomics"},{"key":"10.1016\/j.jdiacomp.2026.109330_bb0125","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.853863","article-title":"Analysis of half a billion datapoints across ten machine-learning algorithms identifies key elements associated with insulin transcription in human pancreatic islet cells","volume":"13","author":"Wong","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jdiacomp.2026.109330_bb0130","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"Huang","year":"2009","journal-title":"Nat Protoc"},{"key":"10.1016\/j.jdiacomp.2026.109330_bb0135","doi-asserted-by":"crossref","first-page":"W216","DOI":"10.1093\/nar\/gkac194","article-title":"DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update)","volume":"50","author":"Sherman","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jdiacomp.2026.109330_bb0140","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1093\/bioinformatics\/btv300","article-title":"GOplot: an R package for visually combining expression data with functional analysis","volume":"31","author":"Walter","year":"2015","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jdiacomp.2026.109330_bb0145","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s00726-010-0784-z","article-title":"Glycation and biomarkers of vascular complications of diabetes","volume":"42","author":"Beisswenger","year":"2012","journal-title":"Amino Acids"},{"key":"10.1016\/j.jdiacomp.2026.109330_bb0150","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1056\/NEJM198711263172206","article-title":"Epidemiologic approach to the etiology of type I diabetes mellitus and its complications","volume":"317","author":"Krolewski","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2026.109330_bb0155","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/BF00284458","article-title":"Diabetic nephropathy in Type 1 (insulin-dependent) diabetes: an epidemiological study","volume":"25","author":"Andersen","year":"1983","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2026.109330_bb0160","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11154-016-9347-2","article-title":"Glucose variability, HbA1c and microvascular complications","volume":"17","author":"Skrha","year":"2016","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.jdiacomp.2026.109330_bb0165","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/ki.1995.236","article-title":"Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. The Diabetes Control and Complications (DCCT) Research Group","volume":"47","year":"1995","journal-title":"Kidney Int"},{"key":"10.1016\/j.jdiacomp.2026.109330_bb0170","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jdiacomp.2026.109330_bb0175","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"Group AC","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2026.109330_bb0180","doi-asserted-by":"crossref","first-page":"995","DOI":"10.2337\/db07-1618","article-title":"Effect of glycemic exposure on the risk of microvascular complications in the diabetes control and complications trial\u2014revisited","volume":"57","author":"Lachin","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2026.109330_bb0185","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJM199807233390404","article-title":"Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction","volume":"339","author":"Haffner","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2026.109330_bb0190","article-title":"Glycated haemoglobin A1c as a risk factor of cardiovascular outcomes and all-cause mortality in diabetic and non-diabetic populations: a systematic review and meta-analysis","volume":"7","author":"Cavero-Redondo","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.jdiacomp.2026.109330_bb0195","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0531-5565(02)00139-0","article-title":"Serum levels of the senescence biomarker clusterin\/apolipoprotein J increase significantly in diabetes type II and during development of coronary heart disease or at myocardial infarction","volume":"37","author":"Trougakos","year":"2002","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.jdiacomp.2026.109330_bb0200","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1021\/pr060489g","article-title":"Proteome analysis of serum from type 2 diabetics with nephropathy","volume":"6","author":"Kim","year":"2007","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jdiacomp.2026.109330_bb0205","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/prca.200600608","article-title":"The discovery of biomarkers for type 2 diabetic nephropathy by serum proteome analysis","volume":"1","author":"Cho","year":"2007","journal-title":"Proteomics Clin Appl"},{"key":"10.1016\/j.jdiacomp.2026.109330_bb0210","doi-asserted-by":"crossref","first-page":"474","DOI":"10.2337\/dc10-0793","article-title":"Serum apolipoprotein AI and B are stronger biomarkers of diabetic retinopathy than traditional lipids","volume":"34","author":"Sasongko","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2026.109330_bb0215","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/eurjpc\/zwac263","article-title":"U-shaped relationship between apolipoprotein A1 levels and mortality risk in men and women","volume":"30","author":"Faaborg-Andersen","year":"2023","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jdiacomp.2026.109330_bb0220","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/prca.201200044","article-title":"Proteome-base biomarkers in diabetes mellitus: progress on biofluids\u2019 protein profiling using mass spectrometry","volume":"6","author":"Isabel Padrao","year":"2012","journal-title":"Proteomics Clin Appl"},{"key":"10.1016\/j.jdiacomp.2026.109330_bb0225","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.2022","article-title":"Association of potential salivary biomarkers with diabetic retinopathy and its severity in type-2 diabetes mellitus: a proteomic analysis by mass spectrometry","volume":"4","author":"Chee","year":"2016","journal-title":"PeerJ"},{"key":"10.1016\/j.jdiacomp.2026.109330_bb0230","first-page":"513","article-title":"Proteomic analysis of urinary protein markers for accurate prediction of diabetic kidney disorder","volume":"53","author":"Jain","year":"2005","journal-title":"J Assoc Physicians India"},{"key":"10.1016\/j.jdiacomp.2026.109330_bb0235","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2022.5116","article-title":"Talin-1 interaction network in cellular mechanotransduction (review)","volume":"49","author":"Zhao","year":"2022","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.jdiacomp.2026.109330_bb0240","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/s41419-023-06235-8","article-title":"Talin-1 inhibits Smurf1-mediated Stat3 degradation to modulate beta-cell proliferation and mass in mice","volume":"14","author":"Hou","year":"2023","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jdiacomp.2026.109330_bb0245","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1074\/jbc.275.4.2607","article-title":"Role of lumican in the corneal epithelium during wound healing","volume":"275","author":"Saika","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jdiacomp.2026.109330_bb0250","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19113635","article-title":"A proteomic approach for understanding the mechanisms of delayed corneal wound healing in diabetic keratopathy using diabetic model rat","volume":"19","author":"Yamamoto","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jdiacomp.2026.109330_bb0255","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1096\/fj.00-0493fje","article-title":"Small proteoglycans in human diabetic nephropathy: discrepancy between glomerular expression and protein accumulation of decorin, biglycan, lumican, and fibromodulin","volume":"15","author":"Schaefer","year":"2001","journal-title":"FASEB J"},{"key":"10.1016\/j.jdiacomp.2026.109330_bb0260","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1006\/exmp.2002.2425","article-title":"Expression of lumican in thickened intima and smooth muscle cells in human coronary atherosclerosis","volume":"72","author":"Onda","year":"2002","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.jdiacomp.2026.109330_bb0265","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/HJH.0b013e3282f4b3d0","article-title":"Accelerated arterial stiffening and gene expression profile of the aorta in patients with coronary artery disease","volume":"26","author":"Fassot","year":"2008","journal-title":"J Hypertens"},{"key":"10.1016\/j.jdiacomp.2026.109330_bb0270","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1369\/0022155420940067","article-title":"The inter-alpha-trypsin inhibitor family: versatile molecules in biology and pathology","volume":"68","author":"Lord","year":"2020","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.jdiacomp.2026.109330_bb0275","doi-asserted-by":"crossref","first-page":"618","DOI":"10.2337\/db23-0564","article-title":"Therapeutic targets for diabetic kidney disease: proteome-wide Mendelian randomization and colocalization analyses","volume":"73","author":"Zhang","year":"2024","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2026.109330_bb0280","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","article-title":"FinnGen provides genetic insights from a well-phenotyped isolated population","volume":"613","author":"Kurki","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.jdiacomp.2026.109330_bb0285","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin C-based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N Engl J Med"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872726000759?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872726000759?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T22:17:18Z","timestamp":1778797038000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872726000759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":57,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1056872726000759"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2026.109330","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unveiling novel biomarkers for diabetes-related complications through large-scale proteomics analysis: A FIELD sub-study","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2026.109330","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors.","name":"copyright","label":"Copyright"}],"article-number":"109330"}}